Boc-piperazine-benzoic acid|CAS 162046-66-4|DC Chemicals

Cas No.:	162046-66-4
Chemical Name:	4-(4-(Tert-butoxycarbonyl)piperazin-1-yl)benzoic acid
Synonyms:	4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid;4-(4-(tert-butoxycarbonyl)piperazin-1-yl)benzoic a;4-(4-carboxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester;4-(4-Carboxyphenyl)piperazine-1-carboxylic acid tert-butyl ester;4-[4-(tert-Butoxycarbonyl)piperazino]benzoic acid;4-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]benzoic Acid;tert-Butyl 4-(4-carboxyphenyl)-1-piperazinecarboxylate;BUTTPARK 98\06-97;4-[N-Boc-piperazino]benzoic acid;4-(4-Boc-1-piperazineyl)benzoic acid;1-(4-carboxyphenyl)-4-Boc piperazine;1-(4-BOC-PIPERAZIN-1-YL)-BENZOIC ACID;1-BOC-4-(4-CARBOXY-PHENYL)-PIPERAZINE;4-(4-BOC-PIPERAZIN-1-YL)-BENZOIC ACID;4-(4-TERT-BUTOXYCARBONYLPIPERAZINE)BENZOIC ACID;4-(4-Carboxyphenyl)piperazine, N1-BOC protected;4-(4-Carboxyphenyl)piperazine-1-carboxylicAcid tert-Butyl Ester;4-[4-[(2-Methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]benzoicacid;4-(4-boc-piperazin-1-yl)benzoic acid;4-[4-(tert-butoxycarbonyl)piperazin-1-yl]benzoic acid;1-boc-4-(4-carboxy-phenyl)-piperazin;1-(4-Boc-Piperazin-1-YL)-Benzoic Acid, 4-(4-Carboxy-Phenyl)-Piperazine-1-Carboxylic Acid Tert-Butyl Ester
SMILES:	O(C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C(N1C([H])([H])C([H])([H])N(C2C([H])=C([H])C(C(=O)O[H])=C([H])C=2[H])C([H])([H])C1([H])[H])=O
Formula:	C₁₆H₂₂N₂O₄
M.Wt:	306.3569
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC65211	KT-474	KT-474 is a highly active and selective, orally bioavailable IRAK4 degrader being developed for the treatment of toll-like receptor (TLR)/interleukin-1 receptor (IL-1R)-driven immune-inflammatory diseases.
DC39826	Homo-PROTAC cereblon degrader 1	Homo-PROTAC cereblon degrader 1, is a cereblon degrader.
DC74523	XY-07-35	XY-07-35 is a potent, selective HDAC6 proteolysis targeting chimera (PROTAC) degrader with IC50 of 48.5 nM.
DC74496	HJM-561	HJM-561 is a potent, selective and orally bioavailable EGFR PROTAC degrader, selectively degrades the EGFR C797S-containing triple mutants Del19/T790M/C797S and L858R/T790M/C797S with DC50 values of 9.2 nM and 5.8 nM, respectively.
DC74494	GNE-0011	GNE-0011 is a monovalent, JQ1-based BRD4 degrader that is not linked to an E3 ligase binder, triggers proteasomal and ubiquitin-dependent selective degradation of BRD4 over BRD2 and BRD3.
DC74479	BSJ-05-037	BSJ-05-037 is a potent and selective heterobifunctional degrader of ITK with DC50 of 17.6-41.8 nM in TCL lines DERL-2 and Hut78.
DC72756	JQAD1	JQAD1 is a CRBN-dependent PROTAC that selectively targets EP300 for degradation. JQAD1 suppresses EP300 expression and the H3K27ac modification. JQAD1 induces apoptosis. JQAD1 can be used in research of cancer.
DC48434	TD-165	TD165(TD 165) is a PROTAC-based cereblon (CRBN) degrader that degrads Cav1.2α with the DC50 of 20.4 nM, comprising a cereblon (CRBN) ligand binding group, a linker and an von Hippel-Landau (VHL) binding group.
DC46405	ARD-2128	ARD2128 is a highly potent, orally bioavailable PROTAC androgen receptor (AR) degrader. ARD-2128 effectively reduces AR protein, suppresses AR-regulated genes in tumor tissues, and inhibits growth of tumor without signs of toxicity. ARD-2128 has the potential for the research of the prostate cancer.
DC46309	Boc-piperazine-benzoic acid	Boc-piperazine-benzoic acid is a PROTAC linker and can be used in the synthesis of PROTACs, such as PROTAC androgen receptor (AR) degrader ARD-2128.